NCT04351880 is a NA clinical trial of Medically Tailored Meals in Heart Failure, sponsored by Kaiser Permanente.

Who is sponsoring NCT04351880?

NCT04351880 is sponsored by Kaiser Permanente.

What drugs are being tested in NCT04351880?

Interventions in NCT04351880: Medically Tailored Meals.

What condition does NCT04351880 study?

NCT04351880 studies Heart Failure, Copd, Liver Failure, Diabetes Mellitus, Cancer, End Stage Renal Disease.

Is NCT04351880 still recruiting?

NCT04351880 is currently completed. Last updated 17 February 2022.

Last reviewed 2022-02-17 · How we verify

NCT04351880

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge

Completed NA Last updated 17 February 2022

What this trial tests

NA trial testing Medically Tailored Meals in Heart Failure in 650 participants. Completed in 31 December 2021.

Timeline

16 April 2020

Primary endpoint
8 September 2021

31 December 2021

Quick facts

Lead sponsor	Kaiser Permanente
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	650
Start date	16 April 2020
Primary completion	8 September 2021
Estimated completion	31 December 2021
Sites	2 locations across United States

Drugs / interventions tested

Medically Tailored Meals

Conditions studied

Heart Failure — all drugs for Heart Failure →
Copd — all drugs for Copd →
Liver Failure — all drugs for Liver Failure →
Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

Kaiser Permanente — full company profile →

Who can join

18 and older, any sex, with Heart Failure or Copd. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if medically tailored meals provided for either 2 weeks or 4 weeks (1 meal per day) to a Kaiser Permanente Colorado (KPCO) member after hospital discharge will improve their health. Medically tailored meals (MTM) are meals that are approved by a dietitian and shown to help people with certain health conditions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Medically Tailored Meals on Clinical Outcomes in Recently Hospitalized High-Risk Adults.
Go AS, Tan TC, Horiuchi KM, Laws D, et al · · 2022 · cited 39× · PMID 35972131 · DOI 10.1097/mlr.0000000000001759

Verify or expand the search:

Other trials of Medically Tailored Meals

Trials testing the same drug.

NCT07251894 — Pilot Study Exploring the Feasibility, Acceptability, and Impact of Medically Tailored Meals on Post-Discharge Recovery · NA · enrolling by invitation
NCT06784310 — Food Insecurity, Social Determinants of Health · NA · completed
NCT06460272 — Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support · NA · completed
NCT04866823 — Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes · NA · completed
NCT04289181 — A Trial to Evaluate Medically Tailored Meals With Patients With Heart Failure · NA · completed

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other Kaiser Permanente trials

Trials by the same sponsor.

NCT07522645 — Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Dis · NA · not yet recruiting
NCT07474038 — AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment · NA · enrolling by invitation
NCT07467668 — Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure · NA · not yet recruiting
NCT07216859 — Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI) · NA · not yet recruiting
NCT07264062 — MetSense Pilot and Feasibility · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04351880 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kaiser Permanente
Last refreshed: 17 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04351880.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing